FABP4 and diabetes mellitus: Since FABP4 can be considered as a remarkable biomarker in patients with diabetes or atherosclerosis, it would be more meaningful to select periodontitis patients with systemic diseases to explore the linking biomarker of periodontitis and systemic diseases.